Quick Answer
biote Corp. reported Cash and Equivalents of $24.12 million for fiscal year 2025.
biote Corp. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $24.12M | -38.7% |
| 2024 | $39.34M | -55.8% |
| 2023 | $89.00M | +12.3% |
| 2022 | $79.23M | +60679.1% |
| 2021 | $130.4K | +8078.1% |
| 2020 | $1.6K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.05M | -26.6% | +43.1% |
| June 30, 2025 | $19.60M | -25.8% | -53.0% |
| March 31, 2025 | $41.70M | -47.1% | +6.0% |
| December 31, 2024 | $39.34M | -55.8% | +2.9% |
| September 30, 2024 | $38.23M | -41.7% | +44.7% |
| June 30, 2024 | $26.42M | -61.4% | -66.5% |
| March 31, 2024 | $78.79M | — | -11.5% |
| December 31, 2023 | $89.00M | +12.3% | +35.7% |
- biote Corp. showed a decrease of -38.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, biote Corp.’s cash and equivalents has grown by 1513262.6% (from $1.6 thousand to $24.12 million).
- The most recent figure is from biote Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: